TGS Baltic advised INVL Baltic Sea Growth Fund on merging the medical clinics of the MediCa Group and InMedica

15.10.2020 TGS Baltic advised INVL Baltic Sea Growth Fund on merging the medical clinics of the MediCa Group and InMedica

TGS Baltic represented the INVL Baltic Sea Growth Fund - a private equity fund of INVL Asset Management, the largest private equity investment fund in the Baltics, on negotiating and signing the transaction to merge the medical clinics of the Medica Group and InMedica klinika.

INVL Baltic Sea Growth Fund owns 70% of InMedica klinika shares through the BSGF Sanus company, meanwhile the Medica Group is owned by the Latvian private healthcare group Repharm Group through its Lithuanian subsidiary RP Pharma.

Following the implementation of the transaction, the joint healthcare facility will operate in 20 Lithuanian cities, providing services to over 200.000 patients at all three levels - from family doctor consultations to complex heart surgeries.

The team working on the merger included executive partner Marius Matonis, partner Aurimas Pauliukevicius and associate Paulius Dabulskis.